Presenilin1 exerts antiproliferative effects by repressing the Wnt/β-catenin pathway in glioblastoma

Sortilin promotes glioblastoma invasion and mesenchymal transition through GSK-3β/β-catenin/twist pathway

(2019) Wei Yang et al.   Cell Death & Disease

Challenges to curing primary brain tumours

(2019) Kenneth Aldape et al.   Nature Reviews Clinical Oncology

The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1

(2018) Hongbin Ma et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Variants in Notch signalling pathway genes, PSEN1 and MAML2, predict overall survival in Chinese patients with epithelial ovarian cancer

(2018) Yuan Xu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015

(2018) Quinn T Ostrom et al.   NEURO-ONCOLOGY

Alzheimer's disease

(2017) C. A. Lane et al.   EUROPEAN JOURNAL OF NEUROLOGY

Adult Glioblastoma

(2017) Brian M. Alexander et al.   JOURNAL OF CLINICAL ONCOLOGY

CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component

(2017) Guiyan Xu et al.   JOURNAL OF NEURO-ONCOLOGY

The past, present, and future of disease-modifying therapies for Alzheimer’s disease

(2017) Kazushi SUZUKI et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer

(2016) Orsolya Galamb et al.   Epigenetics

miR-193a-3p regulation of chemoradiation resistance in oesophageal cancer cells via the PSEN1 gene

(2016) Fang Meng et al.   GENE

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013

(2016) Quinn T. Ostrom et al.   NEURO-ONCOLOGY

Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature

(2014) Karina Kristoffersen et al.   CANCER BIOLOGY & THERAPY

mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc

(2013) Kenta Masui et al.   Cell Metabolism

Genetics of dementia

(2013) Clement T Loy et al.   LANCET

ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro

(2013) J. Xiong et al.   NEURO-ONCOLOGY

Impaired Orthotopic Glioma Growth and Vascularization in Transgenic Mouse Models of Alzheimer's Disease

(2010) D. Paris et al.   JOURNAL OF NEUROSCIENCE

Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells via an Endothelial Cell Intermediate

(2010) Koos E. Hovinga et al.   STEM CELLS

A role for the transcription factor HEY1 in glioblastoma

(2008) Esther Hulleman et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE